Candamo, Amor .
HRN: 26-29-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/12/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
01/12/2025
01/18/2025
IVTT
25mg
Q24h
T/c Late Onset Neonatal Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes